Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study - Franz, David N.; Witt, Olaf (The lancet. Oncology, 2014)
Gesehen am 16.10.2020